RHEB1 insufficiency in aged male mice is associated with stress-induced seizures

Qi Tian, Pavel Gromov, Joachim H. Clement, Yingming Wang, Marc Riemann, Falk Weih, Xiao-Xin Sun, Mushui Dai, Lev Fedorov

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The mechanistic target of rapamycin (mTOR), a protein kinase, is a central regulator of mammalian metabolism and physiology. Protein mTOR complex 1 (mTORC1) functions as a major sensor for the nutrient, energy, and redox state of a cell and is activated by ras homolog enriched in brain (RHEB1), a GTP-binding protein. Increased activation of mTORC1 pathway has been associated with developmental abnormalities, certain form of epilepsy (tuberous sclerosis), and cancer. Clinically, those mTOR-related disorders are treated with the mTOR inhibitor rapamycin and its rapalogs. Because the effects of chronic interference with mTOR signaling in the aged brain are yet unknown, we used a genetic strategy to interfere with mTORC1 signaling selectively by introducing mutations of Rheb1 into the mouse. We created conventional knockout (Rheb1+/−) and gene trap (Rheb1Δ/+) mutant mouse lines. Rheb1-insufficient mice with different combinations of mutant alleles were monitored over a time span of 2 years. The mice did not show any behavioral/neurological changes during the first 18 months of age. However, after aging (> 18 months of age), both the Rheb1+/− and Rheb1Δ /− hybrid males developed rare stress-induced seizures, whereas Rheb1+/− and Rheb1Δ /− females and Rheb1Δ/+ and Rheb1Δ/Δ mice of both genders did not show any abnormality. Our findings suggest that chronic intervention with mTORC1 signaling in the aged brain might be associated with major adverse events.

Original languageEnglish (US)
Pages (from-to)1-14
Number of pages14
JournalGeroScience
DOIs
StateAccepted/In press - Sep 10 2017

Fingerprint

Sirolimus
Seizures
Brain
TOR Serine-Threonine Kinases
Gene Knockout Techniques
Tuberous Sclerosis
GTP-Binding Proteins
Protein Kinases
Oxidation-Reduction
Epilepsy
Alleles
Food
Mutation
Neoplasms
Proteins

Keywords

  • Gene targeting
  • Mice
  • mTOR inhibitor
  • mTORC1
  • Rapamycin
  • Rheb1

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Cite this

Tian, Q., Gromov, P., Clement, J. H., Wang, Y., Riemann, M., Weih, F., ... Fedorov, L. (Accepted/In press). RHEB1 insufficiency in aged male mice is associated with stress-induced seizures. GeroScience, 1-14. https://doi.org/10.1007/s11357-017-9997-3

RHEB1 insufficiency in aged male mice is associated with stress-induced seizures. / Tian, Qi; Gromov, Pavel; Clement, Joachim H.; Wang, Yingming; Riemann, Marc; Weih, Falk; Sun, Xiao-Xin; Dai, Mushui; Fedorov, Lev.

In: GeroScience, 10.09.2017, p. 1-14.

Research output: Contribution to journalArticle

Tian, Qi ; Gromov, Pavel ; Clement, Joachim H. ; Wang, Yingming ; Riemann, Marc ; Weih, Falk ; Sun, Xiao-Xin ; Dai, Mushui ; Fedorov, Lev. / RHEB1 insufficiency in aged male mice is associated with stress-induced seizures. In: GeroScience. 2017 ; pp. 1-14.
@article{8a7649f4d0314904a7e1f8ab817f3053,
title = "RHEB1 insufficiency in aged male mice is associated with stress-induced seizures",
abstract = "The mechanistic target of rapamycin (mTOR), a protein kinase, is a central regulator of mammalian metabolism and physiology. Protein mTOR complex 1 (mTORC1) functions as a major sensor for the nutrient, energy, and redox state of a cell and is activated by ras homolog enriched in brain (RHEB1), a GTP-binding protein. Increased activation of mTORC1 pathway has been associated with developmental abnormalities, certain form of epilepsy (tuberous sclerosis), and cancer. Clinically, those mTOR-related disorders are treated with the mTOR inhibitor rapamycin and its rapalogs. Because the effects of chronic interference with mTOR signaling in the aged brain are yet unknown, we used a genetic strategy to interfere with mTORC1 signaling selectively by introducing mutations of Rheb1 into the mouse. We created conventional knockout (Rheb1+/−) and gene trap (Rheb1Δ/+) mutant mouse lines. Rheb1-insufficient mice with different combinations of mutant alleles were monitored over a time span of 2 years. The mice did not show any behavioral/neurological changes during the first 18 months of age. However, after aging (> 18 months of age), both the Rheb1+/− and Rheb1Δ /− hybrid males developed rare stress-induced seizures, whereas Rheb1+/− and Rheb1Δ /− females and Rheb1Δ/+ and Rheb1Δ/Δ mice of both genders did not show any abnormality. Our findings suggest that chronic intervention with mTORC1 signaling in the aged brain might be associated with major adverse events.",
keywords = "Gene targeting, Mice, mTOR inhibitor, mTORC1, Rapamycin, Rheb1",
author = "Qi Tian and Pavel Gromov and Clement, {Joachim H.} and Yingming Wang and Marc Riemann and Falk Weih and Xiao-Xin Sun and Mushui Dai and Lev Fedorov",
year = "2017",
month = "9",
day = "10",
doi = "10.1007/s11357-017-9997-3",
language = "English (US)",
pages = "1--14",
journal = "GeroScience",
issn = "2509-2715",
publisher = "Springer International Publishing AG",

}

TY - JOUR

T1 - RHEB1 insufficiency in aged male mice is associated with stress-induced seizures

AU - Tian, Qi

AU - Gromov, Pavel

AU - Clement, Joachim H.

AU - Wang, Yingming

AU - Riemann, Marc

AU - Weih, Falk

AU - Sun, Xiao-Xin

AU - Dai, Mushui

AU - Fedorov, Lev

PY - 2017/9/10

Y1 - 2017/9/10

N2 - The mechanistic target of rapamycin (mTOR), a protein kinase, is a central regulator of mammalian metabolism and physiology. Protein mTOR complex 1 (mTORC1) functions as a major sensor for the nutrient, energy, and redox state of a cell and is activated by ras homolog enriched in brain (RHEB1), a GTP-binding protein. Increased activation of mTORC1 pathway has been associated with developmental abnormalities, certain form of epilepsy (tuberous sclerosis), and cancer. Clinically, those mTOR-related disorders are treated with the mTOR inhibitor rapamycin and its rapalogs. Because the effects of chronic interference with mTOR signaling in the aged brain are yet unknown, we used a genetic strategy to interfere with mTORC1 signaling selectively by introducing mutations of Rheb1 into the mouse. We created conventional knockout (Rheb1+/−) and gene trap (Rheb1Δ/+) mutant mouse lines. Rheb1-insufficient mice with different combinations of mutant alleles were monitored over a time span of 2 years. The mice did not show any behavioral/neurological changes during the first 18 months of age. However, after aging (> 18 months of age), both the Rheb1+/− and Rheb1Δ /− hybrid males developed rare stress-induced seizures, whereas Rheb1+/− and Rheb1Δ /− females and Rheb1Δ/+ and Rheb1Δ/Δ mice of both genders did not show any abnormality. Our findings suggest that chronic intervention with mTORC1 signaling in the aged brain might be associated with major adverse events.

AB - The mechanistic target of rapamycin (mTOR), a protein kinase, is a central regulator of mammalian metabolism and physiology. Protein mTOR complex 1 (mTORC1) functions as a major sensor for the nutrient, energy, and redox state of a cell and is activated by ras homolog enriched in brain (RHEB1), a GTP-binding protein. Increased activation of mTORC1 pathway has been associated with developmental abnormalities, certain form of epilepsy (tuberous sclerosis), and cancer. Clinically, those mTOR-related disorders are treated with the mTOR inhibitor rapamycin and its rapalogs. Because the effects of chronic interference with mTOR signaling in the aged brain are yet unknown, we used a genetic strategy to interfere with mTORC1 signaling selectively by introducing mutations of Rheb1 into the mouse. We created conventional knockout (Rheb1+/−) and gene trap (Rheb1Δ/+) mutant mouse lines. Rheb1-insufficient mice with different combinations of mutant alleles were monitored over a time span of 2 years. The mice did not show any behavioral/neurological changes during the first 18 months of age. However, after aging (> 18 months of age), both the Rheb1+/− and Rheb1Δ /− hybrid males developed rare stress-induced seizures, whereas Rheb1+/− and Rheb1Δ /− females and Rheb1Δ/+ and Rheb1Δ/Δ mice of both genders did not show any abnormality. Our findings suggest that chronic intervention with mTORC1 signaling in the aged brain might be associated with major adverse events.

KW - Gene targeting

KW - Mice

KW - mTOR inhibitor

KW - mTORC1

KW - Rapamycin

KW - Rheb1

UR - http://www.scopus.com/inward/record.url?scp=85028994178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028994178&partnerID=8YFLogxK

U2 - 10.1007/s11357-017-9997-3

DO - 10.1007/s11357-017-9997-3

M3 - Article

C2 - 28891034

AN - SCOPUS:85028994178

SP - 1

EP - 14

JO - GeroScience

JF - GeroScience

SN - 2509-2715

ER -